CG Oncology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $4.0 | $1.1 | $0.2 | — |
| Operating income | -$190.8 | -$114.7 | -$55.4 | — |
| Net income | -$161.0 | -$88.0 | -$48.6 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$132.5 | -$78.9 | — | — |
Shares outstanding 88.6M · Free float 80.4%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.